You are here: Industry Insights > pipeline

News List

Endeavor raises $101m in Series B round to progress treatment pipeline Pharmaceutical-Technology
February 09, 2022
One of Endeavor’s pipeline programme, ENV-101, showed greater clinical efficacy and safety in six studies.
Arctic Vision Announces US$32MN in Series A to Expand and Develop Innovative Therapies Pipeline in Ophthalmology prnasia
July 14, 2020
Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, today announced its $32mn Series A financing led by Morningside Ventures, together with its existing investors.
Boehringer Ingelheim, Bridge Biotherapeutics to Collaborate on IPF Pipeline contractpharma
July 24, 2019
Global license agreement aims to develop Bridge Biotherapeutics’ autotaxin inhibitor, BBT-877.
AUM Biosciences expands pipeline with new global license agreement biospectrumasia
July 18, 2019
The second major acquisition sets Singapore headquartered company on course to uniquely drive global therapeutic innovation from Asia
Sanofi Restructures R&D Group contractpharma
June 24, 2019
To eliminate 466 jobs in France and Germany as part of a reorganization to focus on its immuno-oncology pipeline and gene therapies.
ANI Pharmaceuticals Expands Generic Pipeline contractpharma
June 19, 2019
Acquires seven development stage drug products from Coeptis.
Aprecia, CMIC Enter 3DP Pact in Japan contractpharma
March 08, 2019
Will leverage Aprecia’s ZipDose Technology for product license, development, manufacturing, and distribution partnerships.
ReForm Biologics, Astellas Form Collaboration contractpharma
March 07, 2019
Will use ReForm’s technology to help progress Astellas’ biologics pipeline
Biogen acquisition boosts its ophthalmology pipeline cphi-online
March 07, 2019
Nightstar Therapeutics has two potentially first-in-class mid- to late-stage clinical assets as well as preclinical programs.
Novo bags €430M Staten buyout option to boost cardiovascular disease pipeline fiercebiotech
December 26, 2018
Novo Nordisk has landed an option to buy Staten Biotechnology in a €430 million ($485 million) deal. The agreement gives Novo the chance to add an anti-apoC3 antibody treatment for abnormal lipid levels to its pipeline....

Previous page 1 2 3 Next page